This Solicitation opportunity from Department Of Defense was posted on August 19, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.
CONTROLS, RAPID HIV-1/2
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
Active Opportunities Like This One
AI Contract Overview
This contract specifies the procurement of rapid HIV-1/2 antibody test kit controls, designed for use with qualitative, in-vitro immunoassays to detect HIV Type 1 and Type 2 antibodies in whole blood, serum, and plasma. Each unit provides a total of 25 tests and includes one negative control, one HIV-1 positive control, and one HIV-2 control in liquid form. These controls are specifically compatible with end items 6550-01-526-7424 and 6550-01-426-7431. Due to the nature of the product, strict storage requirements must be met, necessitating refrigeration between 2 to 8 degrees Celsius, with a strict instruction not to freeze the contents. The procurement is subject to rigorous technical, quality, and packaging standards. The items must be delivered with a non-extendable shelf life of six months, and no more than three weeks may elapse between the date of manufacture and the date of delivery to the government. All packaging must be commercial grade, capable of protecting contents from damage, and must adhere to Medical Marking Standard No. 1. Labels are required to clearly display the date of manufacture, expiration or retest date, and the contract or lot number. This acquisition is managed by the Department of Defense through the Medical Supply Chain MD Surg FSF.
General Info
Place of Performance
CHEATHAM ANNEX, WILLIAMSBURG, VA, 23185-5830, USASet-Aside
Documents
1AI Contract Breakdown
Uniform Contract FormatContract not broken down yet
CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.
Timeline
Submission Closed
Organization & Contact Information
Full Description
CONTROLS, RAPID HIV-1/2 ANTIBODY TEST KIT
FEATURES TEST CAPABILITY IS 25 TESTS, EACH UNIT
CONSISTS OF 1 NEGATIVE CONTROL, 1 HIV-1
POSITIVE CONTROL, 1 HIV-2 CONTROL; LIQUID
CONTROLS FOR USE WITH THE RAPID<(>,<)>
QUALITATIVE, IN-VITRO IMMUNO-ASSAY FOR
DETECTION OF ANTIBODIES TO HIV TYPE 1 AND
TYPE 2 IN WHOLE BLOOD, SERUM AND PLASMA.
SUITABLE FOR USE WITH END ITEMS
6550-01-526-7424 AND 6550-01-426-7431.
REQUIRES REFRIGERATION STORAGE BETWEEN 2 TO 8 DEGREES CELSIUS
(36 TO 46 DEGREES FAHRENHEIT) DO NOT FREEZE
UNIT OF ISSUE EA (EACH)
..
RA001: THIS DOCUMENT INCORPORATES TECHNICAL AND/OR QUALITY REQUIREMENTS
(IDENTIFIED BY AN 'R' OR AN 'I' NUMBER) SET FORTH IN FULL TEXT IN THE
DLA MASTER LIST OF TECHNICAL AND QUALITY REQUIREMENTS FOUND ON THE WEB
AT:
http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx http://www.dla.mil/HQ/Acquisition/Offers/eProcurement.aspx
FOR SIMPLIFIED ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE SOLICITATION ISSUE DATE OR THE AWARD DATE CONTROLS. FOR LARGE ACQUISITIONS, THE REVISION OF THE MASTER IN EFFECT ON THE RFP ISSUE DATE APPLIES UNLESS A SOLICITATION AMENDMENT INCORPORATES A FOLLOW-ON REVISION, IN WHICH CASE THE AMENDMENT DATE CONTROLS.
..
RD003, COVERED DEFENSE INFORMATION POTENTIALLY APPLIES
..
RP001: DLA PACKAGING REQUIREMENTS FOR PROCUREMENT
..
RQ011: REMOVAL OF GOVERNMENT IDENTIFICATION FROM NON-ACCEPTED SUPPLIES
..
APPLICABLE TO ALL MEDICAL ACQUISITIONS:
PACKAGING AND PACKING SHALL BE COMMERCIAL AS
SPECIFIED IN THE PROCUREMENT DOCUMENT.
EACH COMPLETE UNIT SHALL BE PROPERLY PACKAGED
IN A SUITABLE SEALED UNIT CONTAINER CAPABLE
OF PROTECTING THE CONTENTS FROM DAMAGE AND/OR
BREAKAGE.
UNITS SHALL BE PACKED IN SUITABLE COMMERCIAL
EXTERIOR (SHIPPING) CONTAINERS (EXPORT WHEN
NECESSARY) WHICH SHALL INSURE ACCEPTANCE AND
SAFE DELIVERY BY COMMON OR OTHER CARRIER, AT
THE LOWEST RATE, TO POINT OF DELIVERY CALLED
FOR IN THE CONTRACT OR ORDER.
MATERIAL MUST BE MARKED IAW MEDICAL MARKING
STANDARD NO. 1. THIS SUPERCEDES ALL REFERENCES
TO MIL-STD-129.
SPE2DS-26-T-357S
SECTION B
COPIES OF MEDICAL MARKING STANDARD NO. 1
(MMS NO. 1) MAY BE OBTAINED BY CONTACTING DLA
TROOP SUPPORT VIA EMAIL TO contact@example.gov. MMS NO. 1 IS ALSO AVAILABLE ONLINE AT: https://www.dla.mil/Logistics-Operations/Packaging/
. RS008: Shelf-life requirement RS001 for a TYPE I (CODE F) item with a shelf life of 6 months (non-extendable) applies to this item. SHALL HAVE A SHELF LIFE OF 6 MONTHS. NOT MORE THAN 3 WEEKS SHALL HAVE ELAPSED FROM DATE OF MANUFACTURE TO DATE OF DELIVERY TO THE GOVERNMENT. . SHELF LIFE MARKINGS SHALL BE IN ACCORDANCE WITH THE LATEST REVISION OF MMS1C.
. ALL LABELS SHALL INCLUDE:
DATE OF MANUFACTURE, EXPIRATION, OR RETEST DATE CONTRACT NUMBER/LOT NUMBER. .. ADEQUATE DATA FOR THE NSN/Part Number: 6550-01-529-2236 Quantity: 1 EA Purchase Request: 7017951593QTY: 1 Delivery: 5 days ADO
More opportunities from Department Of Defense → MEDICAL SUPPLY CHAIN MD SURG FSF
Same awarding agency
Earlier notices in this NAICS code
Posted before this notice, open and closed
Find Active Opportunities Like This
Get AI-powered intelligence on the opportunities still open
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
